📣 Introducing Tracenable Pro: Unlock Unlimited Data Exports & Disclosures Access.

Natco Pharma Ltd

Common Name
Natco Pharma
Country
India
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
4,199
Ticker
NATCOPHARM
Exchange
NATIONAL STOCK EXCHANGE OF INDIA
Description
Natco Pharma Ltd. is a prominent pharmaceutical company based in India, specializing in the development and manufacture of generic drugs and active pharmaceutical ingredients (APIs). The company plays...

Natco Pharma's Financial Statements Preview

Below are the financial statements of Natco Pharma, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in millions of INR
2025 as of 2025-03-31
2024 as of 2024-03-31
Assets——
Non-current assets——
Property, plant and equipment
24,319a
22,977a
Capital work-in-progress
2,254a
1,373a
Goodwill
574a
560a
Other intangible assets
2,087a
1,371a
Financial assets——
Investments
1,528a
959a
Other financial assets
1,823a
439a
Deferred tax assets, net
501a
194a
Non-current tax assets, net
261a
-
Other non-current assets
490a
694a
Total non-current assets
33,608a
28,828a
Current assets——
Inventories
7,658a
7,005a
Financial assets——
Investments
3,208a
4,435a
Trade receivables
12,466a
11,889a
Cash and cash equivalents
1,200a
704a
Bank balances other than (iii) above
20,560a
8,825a
Loans
94a
90a
Other financial assets
4,205a
4,528a
Other current assets
3,309a
2,759a
Total current assets
52,700a
40,235a
Total assets
86,308a
69,063a
Equity and liabilities——
Equity——
Equity share capital
358a
358a
Other equity
75,712a
58,173a
Equity attributable to owners of the company
76,070a
58,531a
Non-controlling interests
53a
0a
Total equity
76,123a
58,531a
Liabilities——
Non-current liabilities——
Financial liabilities——
Lease liabilities
46a
53a
Other financial liabilities
46a
40a
Provisions
656a
709a
Deferred tax liabilities, net
2a
2a
Total non-current liabilities
750a
804a
Current liabilities——
Financial liabilities——
Borrowings
2,731a
3,632a
Lease liabilities
17a
27a
Trade payables——
Total outstanding dues of micro and small enterprises
176a
41a
Total outstanding dues of creditors other than micro and small enterprises
2,573a
2,314a
Other financial liabilities
1,146a
1,021a
Other current liabilities
1,223a
1,341a
Provisions
779a
1,029a
Current tax liabilities (net)
790a
323a
Total current liabilities
9,435a
9,728a
Total liabilities
10,185a
10,532a
Total equity and liabilities
86,308a
69,063a
Download Data

Verified Sources Behind Natco Pharma’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Natco Pharma’s data sources below and access millions more through our Disclosure Search.

a. Natco Pharma's Annual Report 2025
a. Natco Pharma's Annual Report 2025
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?